Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data - Investing.com UK
RBC maintains stock target on Sage Therapeutics post-trial results - Investing.com Nigeria
Sage Therapeutics stock holds Market Perform amid setbacks - Investing.com Nigeria
Sage Therapeutics stock holds Market Perform amid setbacks - Investing.com India
RBC maintains stock target on Sage Therapeutics post-trial results - Investing.com India
Sage Therapeutics craters over 20% on study results - XTB
Sage Therapeutics stock holds Market Perform amid setbacks By Investing.com - Investing.com
Sage Therapeutics stops Parkinson’s drug work after data misses, stock drops - Boston Business Journal
Sage Therapeutics stops Parkinson’s drug work after data misses, stock drops - The Business Journals
Sage Therapeutics stops Parkinson's drug work after data misses, stock drops - Boston Business Journal - The Business Journals
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
×